| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/17/2022 |
SC 13G/A
| Belldegrun Arie reports a 6.1% stake in KRONOS BIO, INC. |
| 02/14/2022 |
SC 13G/A
| Belldegrun Arie reports a 5% stake in ALLOGENE THERAPEUTICS, INC. |
| 02/12/2021 |
SC 13G/A
| Belldegrun Arie reports a 4.6% stake in ALLOGENE THERAPEUTICS, INC. |
| 02/13/2020 |
SC 13G/A
| Belldegrun Arie reports a 6% stake in ALLOGENE THERAPEUTICS, INC. |
| 02/13/2019 |
SC 13G
| Belldegrun Arie reports a 9.8% stake in ALLOGENE THERAPEUTICS, INC. |
| 02/14/2017 |
SC 13G/A
| Belldegrun Arie reports a 6.6% stake in KITE PHARMA, INC. |
| 09/08/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/12/2016 |
SC 13G/A
| Belldegrun Arie reports a 6.6% stake in KITE PHARMA, INC. |
| 02/11/2015 |
SC 13G
| Belldegrun Arie reports a 14.5% stake in Kite Pharma, Inc. |
| 02/14/2008 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2007 |
SC 13G/A
| Belldegrun Arie reports a 3.1% stake in Cougar Biotechnology, Inc. |
| 04/13/2006 |
SC 13G
| Belldegrun Arie reports a 9.9% stake in Cougar Biotechnology, Inc. |